Change Request
 
NHS Information Authority

Data Standards Programme

Reference: Change Request 326
Version No:1.9
Subject:DSCN 08/2003 - National Cancer Data Set - Site Specific items: Brain, Sarcoma and Skin Cancer
Type of Change:Revision of NHS data standards
Effective Date:1 March 2003
Reason for Change:Integration of the National Cancer Dataset Site Specific data items into the NHS Data Dictionary Version.2

Background:

The National Cancer Data Set Project, run by the NHS Information Authority, has produced a set of data items relating to the diagnosis and management of cancer.

The purpose of the National Cancer Minimum Data Set is to advise organisations within the National Health Service on a transferable set of data. These data will meet the needs of clinical audit, assist in the generation of National Performance Indicators and will allow outcome assessment.

Data Standards to support parts of the National Cancer Data Set have been released earlier in the following DSCNs:

10/2002 Data Standards: Radiotherapy Treatments
23/2002 Data Standards: Chemotherapy HRGs
30/2002 Data Standards: change to Monitoring of the Cancer Waiting Times
53/2002 Data Standards: National Cancer Data Set
54/2002 Data Standards: National Cancer Data Set - Site Specific items: Breast, Colorectal, Lung, Head & Neck, Urological, Upper Gastro-Intestinal and Gynaecological

More information about the project and the Data Set can be found at:

http://www.nhsia.nhs.uk/cancer/pages/default.asp

This paper defines NHS data standards to support Version 2.1_ISB additional site specific data elements for three types of cancer: Brain, Sarcoma and Skin Cancer. There are no additional items for Cancer Site Specific Brain within this paper.

Summary of changes:
 
Class Definitions
ANTI-CANCER DRUG FRACTION   Change to attributes
BODY SITE   New Class
CANCER CARE PLAN   Change to attributes
CANCER CARE SPELL   Change to description
CANCER CARE SPELL   Change to relationships
CANCER CLINICAL STATUS ASSESSMENT   Change to attributes
DERMATOLOGIST BODY SITE   New Class
DRUG DOSAGE AND ADMINISTRATION   Change to attributes
FRACTION   Change to attributes
PATHOLOGY LAB INVESTIGATION RESULT ITEM   Change to attributes
PATHOLOGY LABORATORY INVESTIGATION   Change to attributes
PATIENT DIAGNOSIS   Change to relationships
PATIENT PROCEDURE   Change to attributes
SARCOMA CARE SPELL   New Class
SARCOMA CONDITION   New Class
SKIN CANCER CARE SPELL   New Class
SKIN CANCER LESION   New Class
SKIN LYMPHOMA MORPHOLOGY   New Class
 
Attribute Definitions
BASAL CELL CLINICAL MORPHOLOGY   New Attribute
BODY SITE CLASSIFICATION   New Attribute
BONE SARCOMA LOCATION   New Attribute
CLINICAL EXCISION MARGIN   New Attribute
CLOSEST MARGIN   New Attribute
DERMATOLOGIST BODY SITE CLASSIFICATION   New Attribute
DISTRIBUTION OF LESIONS PRESENT   New Attribute
DRUG ROUTE OF ADMINISTRATION   Change to description
GENETICALLY DETERMINED SKIN CANCER TYPE   New Attribute
NECROSIS   New Attribute
NEW LESIONS TREATED NUMBER   New Attribute
PATHOLOGY INVESTIGATION TYPE   Change to description
PATHOLOGY SPECIMEN TYPE   New Attribute
PATIENT ON IMMUNOSUPPRESSIVE THERAPY   New Attribute
PERINEURAL INVASION   New Attribute
RECURRENT LESIONS TREATED NUMBER   New Attribute
SARCOMA CONDITION FIRST SEEN   New Attribute
SARCOMA LARGEST DIAMETER   New Attribute
SARCOMA PART SITE   New Attribute
SARCOMA PREDISPOSING CONDITION   New Attribute
SARCOMA RELATION TO DEEP FASCIA   New Attribute
SARCOMA SURGICAL MARGIN   New Attribute
SARCOMA SURGICAL PROCEDURE TYPE   New Attribute
SKIN CANCER LARGEST CLINICAL DIAMETER   New Attribute
SKIN CANCER LESION IDENTIFIER   New Attribute
SKIN CANCER NEW RECURRENT INDICATOR   New Attribute
SKIN CANCER SUBSEQUENT DIAGNOSIS DATE   New Attribute
SKIN LYMPHOMA CLINICAL MORPHOLOGY   New Attribute
SKIN TCELL CLINICAL VARIANT   New Attribute
SKIN TCELL SURFACE AREA   New Attribute
SKIN TUMOUR STATUS   New Attribute
SOFT TISSUE SARCOMA LOCATION   New Attribute
 
Data Elements
BASAL CELL CLINICAL MORPHOLOGY   New DataElement
BONE SARCOMA LOCATION   New DataElement
CLINICAL EXCISION MARGIN   New DataElement
CLOSEST MARGIN   New DataElement
DERMATOLOGIST BODY SITE (SKIN CANCER CARE SPELL)   New DataElement
DERMATOLOGIST BODY SITE (SKIN CANCER LESION)   New DataElement
DISTRIBUTION OF LESIONS PRESENT   New DataElement
GENETICALLY DETERMINED SKIN CANCER TYPE   New DataElement
NECROSIS   New DataElement
NEW LESIONS TREATED NUMBER (CHEMOTHERAPY)   New DataElement
NEW LESIONS TREATED NUMBER (RADIOTHERAPY)   New DataElement
NEW LESIONS TREATED NUMBER (SURGERY)   New DataElement
PATHOLOGY SPECIMEN TYPE   New DataElement
PATIENT ON IMMUNOSUPPRESSIVE THERAPY   New DataElement
PERINEURAL INVASION   New DataElement
PREVIOUS SKIN CANCER   New DataElement
RECURRENT LESIONS TREATED NUMBER (CHEMOTHERAPY)   New DataElement
RECURRENT LESIONS TREATED NUMBER (RADIOTHERAPY)   New DataElement
RECURRENT LESIONS TREATED NUMBER (SURGERY)   New DataElement
SARCOMA CONDITION FIRST SEEN   New DataElement
SARCOMA LARGEST DIAMETER   New DataElement
SARCOMA PART SITE   New DataElement
SARCOMA PREDISPOSING CONDITION (FAMILY)   New DataElement
SARCOMA PREDISPOSING CONDITION (OTHER PHYSICAL)   New DataElement
SARCOMA RELATION TO DEEP FASCIA   New DataElement
SARCOMA SURGICAL MARGIN   New DataElement
SARCOMA SURGICAL PROCEDURE TYPE   New DataElement
SARCOMA TUMOUR SITE   New DataElement
SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER CARE SPELL)   New DataElement
SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER LESION)   New DataElement
SKIN CANCER NEW RECURRENT INDICATOR   New DataElement
SKIN CANCER SUBSEQUENT DIAGNOSIS DATE   New DataElement
SKIN LYMPHOMA CLINICAL MORPHOLOGY   New DataElement
SKIN TCELL CLINICAL VARIANT   New DataElement
SKIN TCELL SURFACE AREA   New DataElement
SKIN TUMOUR STATUS   New DataElement
SOFT TISSUE SARCOMA LOCATION   New DataElement
 
Diagrams
HP420 CANCER SITES - SKIN, BRAIN AND SARCOMA   New Diagram
 
Supporting Information
HP420   New WebPage

Name:Kevin Shine
Date:11 March 2003
Sponsor:Data Standards Team

Note: Additions shown in highlighted with a blue background. Deletions are shown using strikeout.


ANTI-CANCER DRUG FRACTION

Change to Class: change to attributes

Attributes of this Class are:
KANTI-CANCER DRUG FRACTION IDENTIFIER
ONEW LESIONS TREATED NUMBER
   for Basal Cell and Squamous Cell Carcinoma only
ORECURRENT LESIONS TREATED NUMBER
   for Basal Cell and Squamous Cell Carcinoma only
START DATE


top

BODY SITE

Change to Class: New Class

BODY SITE

A type of CLINICAL CLASSIFICATION.

A classification of parts of the body using the OPCS 'Z'coding.

References:
National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralBODY SITES

Attributes of this Class are:
KBODY SITE CLASSIFICATION

Each BODY SITE
may be a tumour site for one or more SARCOMA CARE SPELL


top

CANCER CARE PLAN

Change to Class: change to attributes

Attributes of this Class are:
CANCER CARE PLAN INTENT
OMULTIDISCIPLINARY TEAM DISCUSSION DATE
ONO CANCER TREATMENT REASON
OPATIENT ON IMMUNOSUPPRESSIVE THERAPY
   for skin cancer only
RECURRENCE INDICATOR


top

CANCER CARE SPELL

Change to Class: change to description

A type of CARE SPELL.

The period of time during which a PATIENT who has been diagnosed as suffering from a single site primary cancer may receive care. The period of time during which a PATIENT who has been diagnosed as suffering from a single site primary cancer or, in the case of particular skin cancers, one or more lesions may receive care. The CANCER CARE SPELL starts on the date of the REFERRAL REQUEST from whatever source to the specialist team. It ends when the PATIENT dies.

A recurrence of the original primary cancer at a secondary site is part of the same CANCER CARE SPELL.

If a PATIENT has another primary cancer this will be a new CANCER CARE SPELL. If a PATIENT has another primary cancer this will be a new CANCER CARE SPELL with the following exceptions.

A patient may have many skin cancer Basal Cell Carcinomas diagnosed at the same time, or consecutively during follow-up, or by re-referral. All these skin cancer Basal Cell Carcinomas will be treated under one CANCER CARE SPELL.

For skin cancer Squamous Cell Carcinoma (this includes atypical fibroxanthoma, Merkel cell tumour and all epidermal cell derived invasive malignancies except basal cell carcinoma), most PATIENTS have a single lesion at presentation, but a significant number will get more primaries over a period of time. All these Squamous Cell Carcinomas will be treated under one CANCER CARE SPELL.

For each Kaposi's sarcoma, Malignant Melanoma and cutaneous lymphoma diagnosed there will be one CANCER CARE SPELL.

The CANCER CARE SPELL may only involve diagnostic procedures leading to a diagnosis, for example in cases where the patient refuses treatment, or it may include treatment and follow-up.

References:
National Cancer Data Set Version 1.3_ISB October 2002 National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralCANCER CARE SPELLS


top

CANCER CARE SPELL

Change to Class: change to relationships

Each CANCER CARE SPELL
must be a spell for one and only one PATIENT
must be initiated as a result of one and only one REFERRAL REQUEST
may be the context for one or more ANTI-CANCER DRUG PROGRAMME
may be subject to one or more CANCER CLINICAL STATUS ASSESSMENT
may be associated for endocrine therapy with one or more CLINICAL INTERVENTION
may be associated with one or more PATIENT CLINICAL TRIAL STATUS
may be related as primary diagnosis to one and only one PATIENT DIAGNOSIS
may be associated with one or more PATIENT PROCEDURE


top

CANCER CLINICAL STATUS ASSESSMENT

Change to Class: change to attributes

Attributes of this Class are:
KCLINICAL STATUS ASSESSMENT DATE
MARKER RESPONSE STATUS
METASTATIC STATUS
NODAL STATUS
OPRIMARY TUMOUR STATUS
OSKIN TUMOUR STATUS


top

DERMATOLOGIST BODY SITE

Change to Class: New Class

DERMATOLOGIST BODY SITE

A type of CLINICAL CLASSIFICATION.

A classification of body sites used by the British Association of Dermatologists.

References:
National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralDERMATOLOGIST BODY SITES

Attributes of this Class are:
KDERMATOLOGIST BODY SITE CLASSIFICATION

Each DERMATOLOGIST BODY SITE
may be the skin cancer site for one and only one SKIN CANCER CARE SPELL
may be a site for one or more SKIN CANCER LESION


top

DRUG DOSAGE AND ADMINISTRATION

Change to Class: change to attributes

Attributes of this Class are:
KDRUG DOSAGE AND ADMIN IDENTIFIER
DRUG DOSAGE AND ADMIN SPECIFICATION
DRUG ROUTE OF ADMINISTRATION
   for the delivery of chemotherapy/immunotherapy treatment only
OLAST DOSAGE DATE
OLAST DOSAGE TIME


top

FRACTION

Change to Class: change to attributes

Attributes of this Class are:
KFRACTION NUMBER
KRADIOTHERAPY MACHINE TYPE
FRACTION GIVEN DATE
OHELD OR CANCELLED
ONEW LESIONS TREATED NUMBER
   if for Basal Cell or Squamous Cell Carcinoma only
ORECURRENT LESIONS TREATED NUMBER
   if for Basal Cell or Squamous Cell Carcinoma only


top

PATHOLOGY LAB INVESTIGATION RESULT ITEM

Change to Class: change to attributes

Attributes of this Class are:
OCANCER MARKER LYMPH NODE STATUS
OCANCER VASCULAR OR LYMPHATIC INVASION
OCLOSEST MARGIN
   for sarcoma bone tumours only
OEXCISION MARGIN
   for cancers only
OGRADE OF DIFFERENTIATION
   for cancers only
OINVASIVE LESION SIZE
ONECROSIS
   for sarcoma tumours only
NODES EXAMINED NUMBER
NODES POSITIVE NUMBER
OPERINEURAL INVASION
   for skin cancer only
OSARCOMA RELATION TO DEEP FASCIA
   for sarcoma soft tissue tumours only
SPECIMEN NATURE
OSYNCHRONOUS TUMOUR INDICATOR
   for cancers only
OUNIT OF MEASURE


top

PATHOLOGY LABORATORY INVESTIGATION

Change to Class: change to attributes

Attributes of this Class are:
OMARKER LYMPH NODE RESULT
OPATHOLOGY INVESTIGATION PRIORITY
OPATHOLOGY RESULT DUE DATE
OPATHOLOGY RESULT DUE TIME
OPATHOLOGY SPECIMEN TYPE
   for skin cancers only


top

PATIENT DIAGNOSIS

Change to Class: change to relationships

Each PATIENT DIAGNOSIS
may be recorded for one and only one CONSULTANT EPISODE (ACUTE HOME-BASED)
or may be related to one and only one CONSULTANT EPISODE (HOSPITAL PROVIDER)
or may be related to one and only one OUT-PATIENT ATTENDANCE CONSULTANT
may be the primary diagnosis of one or more CANCER CARE SPELL
may be recorded for one and only one CARE PROGRAMME APPROACH REVIEW
may be recorded for highest one and only one NEONATAL LEVEL OF CARE PERIOD


top

PATIENT PROCEDURE

Change to Class: change to attributes

Attributes of this Class are:
OCOLONOSCOPY INCOMPLETE REASON
   if procedure is colonoscopy
ONEW LESIONS TREATED NUMBER
   if procedure is for treatment of Basal Cell or Squamous Cell Carcinoma only
OPERATIVE PATIENT PROCEDURE INDICATOR
OPATIENT INFORMED BIOPSY RESULT DATE
   colposcopy only
OPATIENT PROCEDURE RESULT
   if procedure is colonoscopy or other for cancer detection
ORECURRENT LESIONS TREATED NUMBER
   if procedure is for treatment of Basal Cell or Squamous Cell Carcinoma only
OSARCOMA SURGICAL MARGIN
   if procedure is for treatment of sarcoma
OSARCOMA SURGICAL PROCEDURE TYPE
   if procedure is for treatment of sarcoma
OSURGICAL URGENCY
   for operative procedures only


top

SARCOMA CARE SPELL

Change to Class: New Class

SARCOMA CARE SPELL

A type of CANCER CARE SPELL.

The period of time during which a PATIENT who has been diagnosed as suffering from sarcoma may receive care.

References:
National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralSARCOMA CARE SPELLS

Attributes of this Class are:
OBONE SARCOMA LOCATION
   if sarcoma is bone tumour
SARCOMA CONDITION FIRST SEEN
SARCOMA LARGEST DIAMETER
SARCOMA PART SITE
OSOFT TISSUE SARCOMA LOCATION
   if sarcoma is soft tissue tumour

Each SARCOMA CARE SPELL
must be care for a tumour at one and only one BODY SITE


top

SARCOMA CONDITION

Change to Class: New Class

SARCOMA CONDITION

A type of PERSON OBSERVATION.

A condition related to sarcoma cancer from which the PERSON may suffer.

References:
National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralSARCOMA CONDITIONS

Attributes of this Class are:
SARCOMA PREDISPOSING CONDITION

This class has no relationships.


top

SKIN CANCER CARE SPELL

Change to Class: New Class

SKIN CANCER CARE SPELL

A type of CANCER CARE SPELL.

The period of time during which a PATIENT may receive care who has been diagnosed as suffering from skin cancer.

For basal cell carcinoma and squamous cell carcinoma, all lesions diagnosed will be included within one SKIN CANCER CARE SPELL.

There will be a new SKIN CANCER CARE SPELL for each malignant melanoma diagnosed, each Kaposi's sarcoma diagnosed and each B-cell or T-cell lymphoma diagnosed.

References:
National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralSKIN CANCER CARE SPELLS

Attributes of this Class are:
OCLINICAL EXCISION MARGIN
   for malignant melanoma excisions only
ODISTRIBUTION OF LESIONS PRESENT
   for B-cell and T-cell lymphomas only
OGENETICALLY DETERMINED SKIN CANCER TYPE
OSKIN CANCER LARGEST CLINICAL DIAMETER
   for malignant melanoma, Karposi's sarcoma and B-cell and T-cell lymphomas only
OSKIN TCELL CLINICAL VARIANT
   for T-cell lymphomas only
OSKIN TCELL SURFACE AREA
   for T-cell lymphomas only

Each SKIN CANCER CARE SPELL
may be malignant melanoma, Karposi's sarcoma, B-cell lymphoma or T-cell lymphoma occurring at one or more DERMATOLOGIST BODY SITE
may be care for one or more SKIN CANCER LESION
may be care for one B-cell or T-cell lymphoma where there are one or more SKIN LYMPHOMA MORPHOLOGY


top

SKIN CANCER LESION

Change to Class: New Class

SKIN CANCER LESION

A skin lesion diagnosed as skin cancer.

For Basal Cell Carcinoma and for Squamous Cell Carcinoma (please note that anything which applies to Squamous Cell Carcinoma also applies to atypical fibroxanthoma, Merkel cell tumour and all epidermal cell derived invasive malignancies except basal cell carcinoma), a PATIENT may have many Basal Cell Carcinomas diagnosed at the same time, or consecutively during follow-up, or by re-referral. Most patients with Squamous Cell Carcinoma have a single lesion at presentation, but a significant number will get more primaries over a period of time. For these cancers each lesion should be separately identified.

References:
National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralSKIN CANCER LESIONS

Attributes of this Class are:
KSKIN CANCER LESION IDENTIFIER
OBASAL CELL CLINICAL MORPHOLOGY
   for Basal Cell Carcinoma only
OCLINICAL EXCISION MARGIN
   for excisions only
SKIN CANCER LARGEST CLINICAL DIAMETER
SKIN CANCER NEW RECURRENT INDICATOR
OSKIN CANCER SUBSEQUENT DIAGNOSIS DATE
   for additional or recurrence of existing lesions

Each SKIN CANCER LESION
Kmust be treated as part of one and only one SKIN CANCER CARE SPELL
must be a lesion occuring at one and only one DERMATOLOGIST BODY SITE


top

SKIN LYMPHOMA MORPHOLOGY

Change to Class: New Class

SKIN LYMPHOMA MORPHOLOGY

The morphology of skin cancer B-cell or T-cell lymphoma.

References:
National Cancer Data Set Version 2.1_ISB October 2002



This class is also known by these names:
ContextAlias
pluralSKIN LYMPHOMA MORPHOLOGIES

Attributes of this Class are:
KSKIN LYMPHOMA CLINICAL MORPHOLOGY

Each SKIN LYMPHOMA MORPHOLOGY
Kmust be a lymphoma related to one and only one SKIN CANCER CARE SPELL


top

BASAL CELL CLINICAL MORPHOLOGY

Change to Attribute: New Attribute

BASAL CELL CLINICAL MORPHOLOGY

This is the morphology of a Basal Cell Carcinoma as determined by a clinician on the basis of the worst clinical area.

National codes:
A Nodular or cystic
B Superficial
C Morphoeic

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

BODY SITE CLASSIFICATION

Change to Attribute: New Attribute

BODY SITE CLASSIFICATION

A classification of body sites at a more detailed level than ICD-10 based on OPCS 'Z' coding.

National codes: Additional to OPCS codes
Z92.8 Specified region of body not elsewhere classified (to be used for multiple body sites)
Z92.9 Region of body not elsewhere classified(to be used for Unknown)

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

BONE SARCOMA LOCATION

Change to Attribute: New Attribute

BONE SARCOMA LOCATION

The nature of a bone sarcoma tumour site.

National codes:
I Intraosseous
E Extraosseous
9 Unknown

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

CLINICAL EXCISION MARGIN

Change to Attribute: New Attribute

CLINICAL EXCISION MARGIN

The excision margin measured clinically prior to surgery for a skin cancer lesion in millimetres. The closest margin should be recorded.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

CLOSEST MARGIN

Change to Attribute: New Attribute

CLOSEST MARGIN

A measurement in millimetres of the distance between the tumour and the resection margin after the tumour has been removed.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

DERMATOLOGIST BODY SITE CLASSIFICATION

Change to Attribute: New Attribute

DERMATOLOGIST BODY SITE CLASSIFICATION

The British Association of Dermatologists' Diagnostic Index Body Site coding.

National codes:
0 Scalp
1 Face
2 Forehead/temples
3 Eyelid/periocular
4 Eye
5 Nose
6 Cheek
7 Lips/perioral
8 Mouth
9 Tongue
A Teeth and Gingivae
B Beard area
C Neck
D Ear/pre/post-auricular
E Toe
F Foot/plantar
G Hand & Foot/palmoplantar
H Hand/palmar
J Finger/thumb
K Forearm/wrist
L Arm
M Leg/ankle
N Thigh
P Fingernails
Q Nails/paronychial
R Toenails
S Trunk
T Flexures
W Genital
X Penis
Y Vulva
a Scrotum
b Perianal/perineal
c Breast/nipple
d Umbilicus
e Axilla

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

DISTRIBUTION OF LESIONS PRESENT

Change to Attribute: New Attribute

DISTRIBUTION OF LESIONS PRESENT

The distribution of lesions for B-cell or T-cell lymphomas.

National codes:
A Solitary
B Locoregional
C Multifocal

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

DRUG ROUTE OF ADMINISTRATION

Change to Attribute: change to description

The method of delivery of the chemotherapy/immunotherapy treatment. The method of delivery of drug treatment.

National codes:
01 Intra-vesicular
02 Oral
03 Topical
04 Intravenous
05 Subcutaneous
97 Other

References:
National Cancer Data Set Version 1.3_ISB October 2002 National Cancer Data Set Version 2.1_ISB October 2002



This attribute is also known by these names:
ContextAlias
pluralDRUG_ROUTES_OF_ADMINISTRATION


top

GENETICALLY DETERMINED SKIN CANCER TYPE

Change to Attribute: New Attribute

GENETICALLY DETERMINED SKIN CANCER TYPE

The type of genetically determined skin cancer syndrome of the PATIENT.

National codes:
G Gorlin syndrome
P Melanoma-prone syndromes
X Xeroderma pigmentosa
M Muir Torre syndrome
O Other

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

NECROSIS

Change to Attribute: New Attribute

NECROSIS

This is the percentage of the tumour that has died due to chemotherapy.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

NEW LESIONS TREATED NUMBER

Change to Attribute: New Attribute

NEW LESIONS TREATED NUMBER

The number of new SKIN CANCER LESIONS treated during the attendance.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

PATHOLOGY INVESTIGATION TYPE

Change to Attribute: change to description

A classification of REFERRALS FOR BIOPSIES.

Classification: National Codes:
a. Cytology
CY Cytology
b. Histology (open biopsy)
BX Biopsy
c. Core biopsy
EX Excision
9 Uncertain/other


References:
National Cancer Data Set Version 2.1_ISB October 2002



This attribute is also known by these names:
ContextAlias
pluralPATHOLOGY INVESTIGATION TYPES


top

PATHOLOGY SPECIMEN TYPE

Change to Attribute: New Attribute

PATHOLOGY SPECIMEN TYPE

A type of specimen to be examined in the PATHOLOGY LABORATORY INVESTIGATION.

National codes:
EX Excision
BXI Incisional (diagnostic) biopsy
BXP Punch biposy
BXS Shave biposy
BXC Curettings
9 Uncertain/other

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

PATIENT ON IMMUNOSUPPRESSIVE THERAPY

Change to Attribute: New Attribute

PATIENT ON IMMUNOSUPPRESSIVE THERAPY

An indication of whether the PATIENT is on any form of immunosuppressive therapy recorded as a risk factor as part of a CANCER CARE PLAN.

National codes:
Y Yes
N No
9 Unknown

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

PERINEURAL INVASION

Change to Attribute: New Attribute

PERINEURAL INVASION

An indication of whether there is any perineural invasion of skin cancer.

National codes:
N No, perineural invasion not present
Y Yes, perineural invasion present
U Uncertain whether perineural invasion is present or not
9 Not known

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

RECURRENT LESIONS TREATED NUMBER

Change to Attribute: New Attribute

RECURRENT LESIONS TREATED NUMBER

The number of SKIN CANCER LESIONS treated during the attendance that are a recurrence of a previous lesion.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SARCOMA CONDITION FIRST SEEN

Change to Attribute: New Attribute

SARCOMA CONDITION FIRST SEEN

On the pathway to a diagnosis of sarcoma, the PATIENT may have undergone a number of procedures. This is the condition of the tumour as first seen by a sarcoma specialist.

National codes:
UT Untouched
NB Needle Biopsy
OB Open Biopsy
EX Excision
LR Local recurrence
NR Not referred
9 Not known

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SARCOMA LARGEST DIAMETER

Change to Attribute: New Attribute

SARCOMA LARGEST DIAMETER

The largest diameter in millimetres of the sarcoma tumour. This may change over time. It may start off as determined by the clinician after examination and then be updated by any information available from images and further updated if/when a specimen is available.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SARCOMA PART SITE

Change to Attribute: New Attribute

SARCOMA PART SITE

The detail of a sarcoma tumour site.

National codes:
PR Proximal
DP Diaphyseal
DS Distal

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SARCOMA PREDISPOSING CONDITION

Change to Attribute: New Attribute

SARCOMA PREDISPOSING CONDITION

A condition (either inherited or other physical condition) from which the PATIENT suffers or is related to the PATIENT, which might indicate a tendency to sarcoma.

National codes:
LF Li-Fraumeni Family
NF NF 1
FP Familial Adenomatous Polyposis
PA Paget's
OD Ollier's Disease
MS Maffucci's Syndrome
EX Exostosis
CH Chondrodysplasia
PR Previous Radiotherapy to site
OT Other

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SARCOMA RELATION TO DEEP FASCIA

Change to Attribute: New Attribute

SARCOMA RELATION TO DEEP FASCIA

This is whether the soft tissue tumour is superficial or deep to the fascia. Any spread through the fascia should be defined as deep.

National codes:
A Superficial
B Deep

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SARCOMA SURGICAL MARGIN

Change to Attribute: New Attribute

SARCOMA SURGICAL MARGIN

The margin of the surgical procedure for the treatment of sarcoma.

National codes:
1 Intralesional
2 Marginal
3 Wide
4 Compartmental
8 Other
9 Unknown

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SARCOMA SURGICAL PROCEDURE TYPE

Change to Attribute: New Attribute

SARCOMA SURGICAL PROCEDURE TYPE

The overall type of the surgical procedure carried out for the treatment of sarcoma.

National codes:
A Amputation
E Simple Excision
R Excision and reconstruct

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN CANCER LARGEST CLINICAL DIAMETER

Change to Attribute: New Attribute

SKIN CANCER LARGEST CLINICAL DIAMETER

The largest clinical in-situ measurement of the diameter of the skin cancer lesion in millimetres.

For Malignant Melanoma, the largest diameter may influence whether a diagnostic biopsy is taken first and may determine the complexity of the surgical excision. For other tumours, the largest diameter may influence the choice of treatment modality.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN CANCER LESION IDENTIFIER

Change to Attribute: New Attribute

SKIN CANCER LESION IDENTIFIER

A unique identifier for a SKIN CANCER LESION.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN CANCER NEW RECURRENT INDICATOR

Change to Attribute: New Attribute

SKIN CANCER NEW RECURRENT INDICATOR

An indicator of whether this lesion is a recurrence of a previous diagnosed lesion.

National codes:
N New lesion
R Recurrence

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN CANCER SUBSEQUENT DIAGNOSIS DATE

Change to Attribute: New Attribute

SKIN CANCER SUBSEQUENT DIAGNOSIS DATE

The date on which an additional or recurrence of an existing SKIN CANCER LESION was diagnosed subsequent to an original diagnosis.

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN LYMPHOMA CLINICAL MORPHOLOGY

Change to Attribute: New Attribute

SKIN LYMPHOMA CLINICAL MORPHOLOGY

For cutaneous B-cell or T-cell lymphoma, this is a classification of the clinical morphology as determined by a clinician on the basis of the worst clinical area.

National codes:
A Patch
B Plaque
C Papule
D Nodule/tumour
E Erythrodermic
F Poikiloderma
G Resolved/regressed

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN TCELL CLINICAL VARIANT

Change to Attribute: New Attribute

SKIN TCELL CLINICAL VARIANT

The clinical variant of a T-cell lymphoma which may not be able to be distinguished pathologically.

The coding system used is ICD-O (International Classification of Diseases for Oncology) Morphology coding, with an additional letter to make the code unique.

National codes:
M97003A Mycosis fungoides
M97013A Sézary syndrome
M97003B Localised MF variants - pagetoid reticulosis (Woringer Kolopp disease)
M97003C Other MF variants - follicular mucinosis
M97003D Other MF variants - granulomatous slack skin
M97183A CD30+ primary cutaneous lymphoproliferative disorders - lymphomatoid papulosis
M97183B CD30+ primary cutaneous lymphoproliferative disorders - primary large cell anaplastic lymphoma
M97083A Subcutaneous panniculitis-like T-cell lymphoma

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN TCELL SURFACE AREA

Change to Attribute: New Attribute

SKIN TCELL SURFACE AREA

The surface area of a T-cell lymphoma classified as T1 or T2.

National codes:
T1 less than or equal to 10%
T2 greater than 10%

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SKIN TUMOUR STATUS

Change to Attribute: New Attribute

SKIN TUMOUR STATUS

The status of a skin cancer tumour at the CANCER CLINICAL STATUS ASSESSMENT.

National codes:
1 Local cutaneous metastases
2 'In transit' metastases
3 Distant cutaneous metastases

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

SOFT TISSUE SARCOMA LOCATION

Change to Attribute: New Attribute

SOFT TISSUE SARCOMA LOCATION

The nature of a soft tissue sarcoma tumour site.

National codes:
C Cutaneous
S Subcutaneous
V Visceral
I Deep to fascia - Intramuscular
E Deep to fascia - Extramuscular
9 Not known

References:
National Cancer Data Set Version 2.1_ISB October 2002


top

BASAL CELL CLINICAL MORPHOLOGY

Change to Data Element: New DataElement

BASAL CELL CLINICAL MORPHOLOGY

Format/length: an1
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralBASAL CELL CLINICAL MORPHOLOGIES


top

BONE SARCOMA LOCATION

Change to Data Element: New DataElement

BONE SARCOMA LOCATION

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralBONE SARCOMA LOCATIONS


top

CLINICAL EXCISION MARGIN

Change to Data Element: New DataElement

CLINICAL EXCISION MARGIN

Format/length: n3
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralCLINICAL EXCISION MARGINS


top

CLOSEST MARGIN

Change to Data Element: New DataElement

CLOSEST MARGIN

Format/length: n3
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralCLOSEST MARGINS


top

DERMATOLOGIST BODY SITE (SKIN CANCER CARE SPELL)

Change to Data Element: New DataElement

DERMATOLOGIST BODY SITE (SKIN CANCER CARE SPELL)

Format/length: an1
HES item:
National Codes:
Default Codes:

Notes:
If the diagnosis is malignant melanoma, Kaposi's sarcoma, B-cell lymphoma or T-cell lymphoma, this is the DERMATOLOGIST BODY SITE of the SKIN CANCER CARE SPELL.



This data element is also known by these names:
ContextAlias
pluralDERMATOLOGIST BODY SITES (SKIN CANCER CARE SPELL)


top

DERMATOLOGIST BODY SITE (SKIN CANCER LESION)

Change to Data Element: New DataElement

DERMATOLOGIST BODY SITE (SKIN CANCER LESION)

Format/length: an1
HES item:
National Codes:
Default Codes:

Notes:
If the diagnosis is Basal Cell Carcinoma or Squamous Cell Carcinoma, this is the DERMATOLOGIST BODY SITE of each SKIN CANCER LESION as there may be several lesions for a single SKIN CANCER CARE SPELL.



This data element is also known by these names:
ContextAlias
pluralDERMATOLOGIST BODY SITES (SKIN CANCER LESION)


top

DISTRIBUTION OF LESIONS PRESENT

Change to Data Element: New DataElement

DISTRIBUTION OF LESIONS PRESENT

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralDISTRIBUTION OF LESIONS PRESENT


top

GENETICALLY DETERMINED SKIN CANCER TYPE

Change to Data Element: New DataElement

GENETICALLY DETERMINED SKIN CANCER TYPE

Format/length: an1
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralGENETICALLY DETERMINED SKIN CANCER TYPES


top

NECROSIS

Change to Data Element: New DataElement

NECROSIS

Format/length: n3
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralNECROSES


top

NEW LESIONS TREATED NUMBER (CHEMOTHERAPY)

Change to Data Element: New DataElement

NEW LESIONS TREATED NUMBER (CHEMOTHERAPY)

Format/length: n3
HES item:
National Codes:
Default Codes:

Notes:
NEW LESIONS TREATED NUMBER (CHEMOTHERAPY) is the same as attribute NEW LESIONS TREATED NUMBER of ANTI-CANCER DRUG FRACTION where treatment for Basal Cell Carcinoma or Squamous Cell Carcinoma involved Chemotherapy.

For Basal Cell Carcinoma and Squamous Cell Carcinoma, there is no need to report on an ANTI-CANCER DRUG FRACTION for each lesion. If the same procedure(s) are taking place on a number of lesions then this site specific cancer data item will be recorded.



This data element is also known by these names:
ContextAlias
pluralNEW LESIONS TREATED NUMBERS (CHEMOTHERAPY)


top

NEW LESIONS TREATED NUMBER (RADIOTHERAPY)

Change to Data Element: New DataElement

NEW LESIONS TREATED NUMBER (RADIOTHERAPY)

Format/length: n3
HES item:
National Codes:
Default Codes:

Notes:
NEW LESIONS TREATED NUMBER (RADIOTHERAPY) is the same as attribute NEW LESIONS TREATED NUMBER of FRACTION where treatment for Basal Cell Carcinoma or Squamous Cell Carcinoma involved Radiotherapy.

For Basal Cell Carcinoma and Squamous Cell Carcinoma, there is no need to report on a FRACTION for each lesion. If the same procedure(s) are taking place on a number of lesions then this site specific cancer data item will be recorded.



This data element is also known by these names:
ContextAlias
pluralNEW LESIONS TREATED NUMBERS (RADIOTHERAPY)


top

NEW LESIONS TREATED NUMBER (SURGERY)

Change to Data Element: New DataElement

NEW LESIONS TREATED NUMBER (SURGERY)

Format/length: n3
HES item:
National Codes:
Default Codes:

Notes:
NEW LESIONS TREATED NUMBER (SURGERY) is the same as attribute NEW LESIONS TREATED NUMBER of PATIENT PROCEDURE where treatment for Basal Cell Carcinoma or Squamous Cell Carcinoma involved Surgery.

For Basal Cell Carcinoma and Squamous Cell Carcinoma, there is no need to report on a PATIENT PROCEDURE for each lesion. If the same procedure(s) are taking place on a number of lesions then this site specific cancer data item will be recorded.



This data element is also known by these names:
ContextAlias
pluralNEW LESIONS TREATED NUMBERS (SURGERY)


top

PATHOLOGY SPECIMEN TYPE

Change to Data Element: New DataElement

PATHOLOGY SPECIMEN TYPE

Format/length: an3
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralPATHOLOGY SPECIMEN TYPES


top

PATIENT ON IMMUNOSUPPRESSIVE THERAPY

Change to Data Element: New DataElement

PATIENT ON IMMUNOSUPPRESSIVE THERAPY

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralPATIENT ON IMMUNOSUPPRESSIVE THERAPIES


top

PERINEURAL INVASION

Change to Data Element: New DataElement

PERINEURAL INVASION

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralPERINEURAL INVASIONS


top

PREVIOUS SKIN CANCER

Change to Data Element: New DataElement

PREVIOUS SKIN CANCER

Format/length: an5
HES item:
National Codes:
Default Codes:

Notes:
Derived from CLINICAL INFORMATION FOR PERSON. This will be the ICD-10 coding of a previous diagnosis of a skin cancer with one of the following codes:

For Basal Cell Carcinoma or Squamous Cell Carcinoma (please note that anything which applies to Squamous Cell Carcinoma also applies to atypical fibroxanthoma, Merkel cell tumour and all epidermal cell derived invasive malignancies except basal cell carcinoma).

C44.0 Skin of lip
C44.1 Skin of eyelid including canthus
C44.2 Skin of ear and external auricular canal
C44.3 Skin of other and unspecified parts of face
C44.4 Skin of scalp and neck
C44.5 Skin of trunk
C44.6 Skin of upper limb, including shoulder
C44.7 Skin of lower limb including hip
C44.8 Overlapping lesion of skin
C44.9 Malignant neoplasm of skin, unspecified
   
For Malignant Melanoma
C43.0 Malignant melanoma of lip
C43.1 Malignant melanoma of eyelid including canthus
C43.2 Malignant melanoma of ear and external auricular canal
C43.3 Malignant melanoma of other and unspecified parts of face
C43.4 Malignant melanoma of scalp and neck
C43.5 Malignant melanoma of trunk
C43.6 Malignant melanoma of upper limb, including shoulder
C43.7 Malignant melanoma of lower limb including hip
C43.8 Overlapping malignant melanoma of skin
C43.9 Malignant melanoma of skin, unspecified
D03.0 Melanoma in situ of lip
D03.1 Melanoma in situ of eyelid including canthus
D03.2 Melanoma in situ of ear and external auricular canal
D03.3 Melanoma in situ of other and unspecified parts of face
D03.4 Melanoma in situ of scalp and neck
D03.5 Melanoma in situ of trunk
D03.6 Melanoma in situ of upper limb, including shoulder
D03.7 Melanoma in situ of lower limb including hip
D03.8 Melanoma in situ of other sites
D03.9 Melanoma in situ unspecified
   
For cutaneous lymphomas
C84.0 Mycosis fungoides
C84.1 Sézary disease
C84.2 T-zone lymphoma
C84.3 Lymphoepitheliod lymphoma
C84.4 Peripheral T-cell lymphoma
C84.5 Other and unspecified T-cell lymphomas
C85.1 B-cell lymphoma, unspecified
   
For Kaposi's sarcoma
C46.0 Kaposi's sarcoma of skin
C46.1 Kaposi's sarcoma of soft tissue
C46.2 Kaposi's sarcoma of palate
C46.3 Kaposi's sarcoma of lymph nodes
C46.7 Kaposi's sarcoma of other sites
C46.8 Kaposi's sarcoma of other organs
C46.9 Kaposi's sarcoma, unspecified



This data element is also known by these names:
ContextAlias
pluralPREVIOUS SKIN CANCERS


top

RECURRENT LESIONS TREATED NUMBER (CHEMOTHERAPY)

Change to Data Element: New DataElement

RECURRENT LESIONS TREATED NUMBER (CHEMOTHERAPY)

Format/length: n3
HES item:
National Codes:
Default Codes:

Notes:
RECURRENT LESIONS TREATED NUMBER (CHEMOTHERAPY) is the same as attribute RECURRENT LESIONS TREATED NUMBER of ANTI-CANCER DRUG FRACTION, where treatment for Basal Cell Carcinoma or Squamous Cell Carcinoma involved Chemotherapy.

For Basal Cell Carcinoma and Squamous Cell Carcinoma, there is no need to report on an ANTI-CANCER DRUG FRACTION for each lesion. If the same procedure(s) are taking place on a number of lesions, then this site specific cancer data item will be recorded.



This data element is also known by these names:
ContextAlias
pluralRECURRENT LESIONS TREATED NUMBERS (CHEMOTHERAPY)


top

RECURRENT LESIONS TREATED NUMBER (RADIOTHERAPY)

Change to Data Element: New DataElement

RECURRENT LESIONS TREATED NUMBER (RADIOTHERAPY)

Format/length: n3
HES item:
National Codes:
Default Codes:

Notes:
RECURRENT LESIONS TREATED NUMBER (RADIOTHERAPY) is the same as attribute RECURRENT LESIONS TREATED NUMBER of the FRACTION, where treatment for Basal Cell Carcinoma or Squamous Cell Carcinoma involved Radiotherapy.

For Basal Cell Carcinoma and Squamous Cell Carcinoma, there is no need to report on a FRACTION for each lesion. If the same procedure(s) are taking place on a number of lesions, then this site specific cancer data item will be recorded.



This data element is also known by these names:
ContextAlias
pluralRECURRENT LESIONS TREATED NUMBERS (RADIOTHERAPY)


top

RECURRENT LESIONS TREATED NUMBER (SURGERY)

Change to Data Element: New DataElement

RECURRENT LESIONS TREATED NUMBER (SURGERY)

Format/length: n3
HES item:
National Codes:
Default Codes:

Notes:
RECURRENT LESIONS TREATED NUMBER (SURGERY) is the same as attribute RECURRENT LESIONS TREATED NUMBER of the PATIENT PROCEDURE, where treatment for Basal Cell Carcinoma or Squamous Cell Carcinoma involved Surgery.

For Basal Cell Carcinoma and Squamous Cell Carcinoma, there is no need to report on a PATIENT PROCEDURE for each lesion. If the same procedure(s) are taking place on a number of lesions, then this site specific cancer data item will be recorded.



This data element is also known by these names:
ContextAlias
pluralRECURRENT LESIONS TREATED NUMBERS (SURGERY)


top

SARCOMA CONDITION FIRST SEEN

Change to Data Element: New DataElement

SARCOMA CONDITION FIRST SEEN

Format/length: an2
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSARCOMAS CONDITION FIRST SEEN


top

SARCOMA LARGEST DIAMETER

Change to Data Element: New DataElement

SARCOMA LARGEST DIAMETER

Format/length: n3
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSARCOMAS LARGEST DIAMETER


top

SARCOMA PART SITE

Change to Data Element: New DataElement

SARCOMA PART SITE

Format/length: an2
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSARCOMAS PART SITE


top

SARCOMA PREDISPOSING CONDITION (FAMILY)

Change to Data Element: New DataElement

SARCOMA PREDISPOSING CONDITION (FAMILY)

Format/length: an2
HES item:
National Codes:
Default Codes:

Notes:
Any inherited or family SARCOMA PREDISPOSING CONDITION.

Allowable codes are as follows:
LF Li-Fraumeni Family
NF NF 1
FP Familial Adenomatous Polyposis
PA Paget's
OD Ollier's Disease
MS Maffucci's Syndrome
EX Exostosis
CH Chondrodysplasia



This data element is also known by these names:
ContextAlias
pluralSARCOMA PREDISPOSING CONDITIONS (FAMILY)


top

SARCOMA PREDISPOSING CONDITION (OTHER PHYSICAL)

Change to Data Element: New DataElement

SARCOMA PREDISPOSING CONDITION (OTHER PHYSICAL)

Format/length: an2
HES item:
National Codes:
Default Codes:

Notes:
Any physical SARCOMA PREDISPOSING CONDITION other than family or inherited conditions.

Allowable codes are as follows:
PR Previous Radiotherapy to site
OT Other



This data element is also known by these names:
ContextAlias
pluralSARCOMA PREDISPOSING CONDITIONS (OTHER PHYSICAL)


top

SARCOMA RELATION TO DEEP FASCIA

Change to Data Element: New DataElement

SARCOMA RELATION TO DEEP FASCIA

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSARCOMA RELATION TO DEEP FASCIAS


top

SARCOMA SURGICAL MARGIN

Change to Data Element: New DataElement

SARCOMA SURGICAL MARGIN

Format/length: n1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSARCOMA SURGICAL MARGINS


top

SARCOMA SURGICAL PROCEDURE TYPE

Change to Data Element: New DataElement

SARCOMA SURGICAL PROCEDURE TYPE

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSARCOMA SURGICAL PROCEDURE TYPES


top

SARCOMA TUMOUR SITE

Change to Data Element: New DataElement

SARCOMA TUMOUR SITE

Format/length: an5
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:

Notes:
The BODY SITE CLASSIFICATION of a sarcoma tumour.



This data element is also known by these names:
ContextAlias
pluralSARCOMA TUMOUR SITES


top

SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER CARE SPELL)

Change to Data Element: New DataElement

SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER CARE SPELL)

Format/length: n3
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:

Notes:
If the diagnosis is malignant melanoma, Kaposi's sarcoma, B-cell lymphoma or T-cell lymphoma, this is the SKIN CANCER LARGEST CLINICAL DIAMETER of the SKIN CANCER CARE SPELL.



This data element is also known by these names:
ContextAlias
pluralSKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER CARE SPELLS)


top

SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER LESION)

Change to Data Element: New DataElement

SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER LESION)

Format/length: n3
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:

Notes:
If the diagnosis is Basal Cell Carcinoma or Squamous Cell Carcinoma, this is the SKIN CANCER LARGEST CLINICAL DIAMETER of each SKIN CANCER LESION as there may be several lesions for a single SKIN CANCER CARE SPELL.



This data element is also known by these names:
ContextAlias
pluralSKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER LESIONS)


top

SKIN CANCER NEW RECURRENT INDICATOR

Change to Data Element: New DataElement

SKIN CANCER NEW RECURRENT INDICATOR

Format/length: an1
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSKIN CANCER NEW RECURRENT INDICATORS


top

SKIN CANCER SUBSEQUENT DIAGNOSIS DATE

Change to Data Element: New DataElement

SKIN CANCER SUBSEQUENT DIAGNOSIS DATE

Format/length: ccyymmdd
HES item:
National Codes:
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSKIN CANCER SUBSEQUENT DIAGNOSIS DATES


top

SKIN LYMPHOMA CLINICAL MORPHOLOGY

Change to Data Element: New DataElement

SKIN LYMPHOMA CLINICAL MORPHOLOGY

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSKIN LYMPHOMA CLINICAL MORPHOLOGIES


top

SKIN TCELL CLINICAL VARIANT

Change to Data Element: New DataElement

SKIN TCELL CLINICAL VARIANT

Format/length: an7
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSKIN TCELL CLINICAL VARIANTS


top

SKIN TCELL SURFACE AREA

Change to Data Element: New DataElement

SKIN TCELL SURFACE AREA

Format/length: an2
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSKIN TCELL SURFACE AREAS


top

SKIN TUMOUR STATUS

Change to Data Element: New DataElement

SKIN TUMOUR STATUS

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSKIN TUMOUR STATUSES


top

SOFT TISSUE SARCOMA LOCATION

Change to Data Element: New DataElement

SOFT TISSUE SARCOMA LOCATION

Format/length: an1
HES item:
National Codes: Press Definition button for the National Codes
Default Codes:



This data element is also known by these names:
ContextAlias
pluralSOFT TISSUE SARCOMA LOCATIONS


top

HP420 CANCER SITES - SKIN, BRAIN AND SARCOMA

Change to Diagram: New Diagram


 HP420 Cancer Sites - Skin, Brain and Sarcoma 


top

HP420

Change to Supporting Information: New WebPage

Model View Diagram - Overview

HP420 - Cancer Care - Skin and Sarcoma site specific data

  1. This diagram shows the class types relevant to site specfic data in the treatment of cancer for skin and sarcoma.

  1. A CANCER CARE SPELL may be a SKIN CANCER CARE SPELL or SARCOMA CARE SPELL depending on the type of cancer being treated.

  1. SARCOMA CARE SPELL is related to a particular BODY SITE.

  1. The SKIN CANCER CARE SPELL is related to a DERMATOLOGIST BODY SITE and may have a number of SKIN CANCER LESIONS diagnosed which are found at other DERMATOLOGIST BODY SITES. Each SKIN CANCER CARE SPELL may have a number of different SKIN LYMPHOMA MORPHOLOGIES.

  1. Each CANCER CARE SPELL may have a primary PATIENT DIAGNOSIS and a number of PERSON OBSERVATIONS WITHIN CARE SPELLS, one of which will be the SARCOMA CONDITION.


top